Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
55 to 75
Pharmaceutical / Industry
FE 200486 CS25
EudraCT Number: 2007-003578-04, NCT00527488
2.
Phase II Study of ASP3550 in Patients With Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
20 and over
Pharmaceutical / Industry
3550-CL-0003
NCT00568516
3.
Degarelix as Second-Line Hormonal Treatment After Prostate-Specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
FE200486 CS27
NCT00738673
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
